Combination therapy including 9-nitro-20(S)-camptothecin
US6191119A · kind A · utility
13Cited by
1References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 15, 1999 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Oct 15, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation such as cancer and restenosis is provided. The method comprises: delivering to the patient a therapeutically effective amount of 9-nitro-20(S)-camptothecin in combination with an effective amount of an antibiotic agent such as doxorubicin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.